United States Therapeutic Nuclear Medicines Market was valued at USD 2.24 Billion in 2022 and is projected to reach USD 3.89 Billion by 2030, growing at a CAGR of 7.16% from 2024 to 2030.
The US Therapeutic Nuclear Medicines Market is rapidly expanding, driven by the growing demand for advanced healthcare treatments and improved diagnostic solutions. This sector, which utilizes radioactive substances for medical treatment, is crucial in the management of cancer, thyroid disorders, and certain neurological diseases. With increasing awareness and research breakthroughs, industries like pharmaceuticals and healthcare are increasingly relying on therapeutic nuclear medicines to address complex health conditions.
The therapeutic nuclear medicines market is classified into various types based on their applications, with key categories including targeted therapies for cancers, particularly prostate and thyroid cancers. For instance, radiopharmaceuticals such as iodine-131 and radium-223 have gained prominence due to their effectiveness in treating specific types of cancer. This trend is fueled by the growing need for personalized medicine, where treatment regimens are tailored to individual patient profiles for higher efficacy and fewer side effects.
Industries across the healthcare spectrum, including diagnostic imaging, oncology, and therapeutic drug development, are significantly impacting the growth of this market. With advancements in technology, new isotopes and delivery methods are being developed to improve the precision of treatments. The US government has also been playing a pivotal role in supporting nuclear medicine through funding for research and development, encouraging growth in both the supply and demand for these treatments.
Furthermore, the demand for nuclear medicine is expected to rise in the coming years due to an aging population, which typically experiences more complex medical conditions that require these targeted therapies. Medical centers and hospitals, especially those specializing in oncology and endocrinology, are projected to see an increase in the adoption of therapeutic nuclear medicines, as these treatments offer high specificity, reducing damage to surrounding healthy tissue.
The need for nuclear-based therapeutic solutions is not only seen in hospitals but also in research institutes focused on drug discovery and medical advancements. This surge in demand is further exemplified by growing investments from biotech companies and pharmaceutical industries exploring the potential of nuclear medicine to develop life-saving therapies.
In addition to the healthcare sector, industries such as nuclear engineering and radiopharmaceutical production are aligning their efforts to meet the demand for these cutting-edge solutions. The ongoing collaboration between various sectors is driving innovation in this market, which will likely continue to expand in the coming years, contributing to the overall growth of the healthcare industry.
The US Therapeutic Nuclear Medicines Market Type and requirement from industries is expected to witness further advancements, opening up numerous opportunities for various sectors involved in the development, production, and distribution of nuclear medicines.
Get an In-Depth Research Analysis of the US Therapeutic Nuclear Medicines Market Size And Forecast [2025-2032]
Cardinal Health Inc.
Mallinckrodt plc.
GE Healthcare
Lantheus Medical Imaging Inc.
Bayer AG
Bracco Imaging S.p.A
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Therapeutic Nuclear Medicines Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Therapeutic Nuclear Medicines Market
Alpha Emitters
Beta Emitters
Gamma Emitters
Auger Electron Emitters
Cancer Treatment
Cardiovascular Disease Management
Neurological Disorders
Endocrine Disorders
Palliative Care
Intravenous Administration
Oral Administration
Intrathecal Administration
Local Administration
Radioisotopes
Radiopharmaceuticals
Radiolabeled Antibodies
Therapeutic Devices
Hospitals and Clinics
Diagnostic Centers
Research Laboratories
Pharmaceutical Companies
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Therapeutic Nuclear Medicines Market Research Analysis
1. Introduction of the US Therapeutic Nuclear Medicines Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Therapeutic Nuclear Medicines Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Therapeutic Nuclear Medicines Market, By Type
6. US Therapeutic Nuclear Medicines Market, By Application
7. US Therapeutic Nuclear Medicines Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Therapeutic Nuclear Medicines Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/